These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25165638)

  • 41. Current treatment options for acanthosis nigricans.
    Patel NU; Roach C; Alinia H; Huang WW; Feldman SR
    Clin Cosmet Investig Dermatol; 2018; 11():407-413. PubMed ID: 30122971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acanthosis nigricans is a reliable cutaneous marker of insulin resistance in obese Japanese children.
    Yamazaki H; Ito S; Yoshida H
    Pediatr Int; 2003 Dec; 45(6):701-5. PubMed ID: 14651545
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical significance of pancreatic beta-cell function in obese children with acanthosis nigricans].
    Liang XJ; Zhu C; Yan C; Ni GC; Liu ZL; Du ZM; Li M
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):405-7. PubMed ID: 15265420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment options in insulin resistance obesity-related acanthosis nigricans.
    Romo A; Benavides S
    Ann Pharmacother; 2008 Jul; 42(7):1090-4. PubMed ID: 18492785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acanthosis Nigricans among Native Americans: an indicator of high diabetes risk.
    Stuart CA; Smith MM; Gilkison CR; Shaheb S; Stahn RM
    Am J Public Health; 1994 Nov; 84(11):1839-42. PubMed ID: 7977931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ophthalmic manifestations of acanthosis nigricans.
    Pinto GL; Meyer DR
    Ophthalmic Plast Reconstr Surg; 1994 Mar; 10(1):49-50. PubMed ID: 8193074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal nevus): three cases].
    Petit A; Lemarchand-Venencie F; Pinquier L; Lebbe C; Bourrat E
    Ann Dermatol Venereol; 2012 Mar; 139(3):183-8. PubMed ID: 22401682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and significance of acanthosis nigricans in an adult obese population.
    Hud JA; Cohen JB; Wagner JM; Cruz PD
    Arch Dermatol; 1992 Jul; 128(7):941-4. PubMed ID: 1626961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acanthosis Nigricans, insulin resistance (HOMA) and dyslipidemia among Native American children.
    Copeland K; Pankratz K; Cathey V; Immohotichey P; Maddox J; Felton B; McIntosh R; Parker D; Burgin C; Blackett P
    J Okla State Med Assoc; 2006 Jan; 99(1):19-24. PubMed ID: 16499154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acanthosis nigricans associated with hepatolenticular degeneration.
    Thaipisuttikul Y
    J Dermatol; 1997 Jun; 24(6):395-400. PubMed ID: 9241968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Mutation in INSR in a Child Presenting with Severe Acanthosis Nigricans.
    Tuhan H; Ceylaner S; Nalbantoğlu Ö; Acar S; Abacı A; Böber E; Demir K
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):371-374. PubMed ID: 28663160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acanthosis nigricans, hypothyroidism, and insulin resistance.
    Matsuoka LY; Wortsman J; Gavin JR; Kupchella CE; Dietrich JG
    Am J Med; 1986 Jul; 81(1):58-62. PubMed ID: 3728554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acromegaly presenting as cutis verticis gyrata.
    Al-Bedaia M; Al-Khenaizan AS
    Int J Dermatol; 2008 Feb; 47(2):164. PubMed ID: 18211488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin resistance in obese adolescents.
    Li HJ; Huang CY; Lee HC; Chen MR; Lo FS; Lin CH; Wang AM; Shih BF; Lee YJ
    Acta Paediatr Taiwan; 2005; 46(2):61-6. PubMed ID: 16302580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study.
    Bellot-Rojas P; Posadas-Sanchez R; Caracas-Portilla N; Zamora-Gonzalez J; Cardoso-Saldaña G; Jurado-Santacruz F; Posadas-Romero C
    J Drugs Dermatol; 2006 Oct; 5(9):884-9. PubMed ID: 17039655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acanthosis nigricans.
    Stuart CA; Driscoll MS; Lundquist KF; Gilkison CR; Shaheb S; Smith MM
    J Basic Clin Physiol Pharmacol; 1998; 9(2-4):407-18. PubMed ID: 10212845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laparoscopic sleeve gastrectomy improves body composition and alleviates insulin resistance in obesity related acanthosis nigricans.
    Zhang Y; Zhu C; Wen X; Wang X; Li L; Rampersad S; Lu L; Zhou D; Qian C; Cui R; Zhang M; Yang P; Qu S; Bu L
    Lipids Health Dis; 2017 Nov; 16(1):209. PubMed ID: 29115953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of obesity and hyperinsulinemia in the insulin resistance of obese subjects with the clinical triad of polycystic ovaries, hirsutism and acanthosis nigricans.
    Wajchenberg BL; Giannella-Neto D; Lerario AC; Marcondes JA; Ohnuma LY
    Horm Res; 1988; 29(1):7-13. PubMed ID: 3397043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The obesity syndrome and acanthosis nigricans. Acanthosis nigricans is a common cosmetic problem providing epidemiological clues to the obesity syndrome, the insulin-resistance syndrome, the thrifty metabolism, dyslipidaemia, hypertension and diabetes mellitus type II.
    Maitra SK; Rowland Payne CM
    J Cosmet Dermatol; 2004 Dec; 3(4):202-10. PubMed ID: 17166107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Idiopathic eruptive macular pigmentation or acanthosis nigricans?
    Joshi R; Palwade PK
    Indian J Dermatol Venereol Leprol; 2010; 76(5):591. PubMed ID: 20827015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.